Integrase Inhibitors Market is Anticipated to Witness High Growth Owing to Increasing Prevalence of HIV

 

Integrase Inhibitors Market
Integrase Inhibitors Market


The integrase inhibitors market comprises drugs that inhibit HIV integrase, a viral enzyme that is essential for HIV replication. These inhibitors block integration and prevent spreading the virus to other cells. The global integrase inhibitors market is estimated to be valued at US$ 33.8 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031.


The market for integrase inhibitors has been growing at a steady pace owing to the rising prevalence of HIV infections across the world. According to UNAIDS, around 38 million people were living with HIV globally at the end of 2020. Effective use of integrase inhibitors has helped in improving the lives of HIV patients by reducing viral load and limiting the progression of AIDS. Other advantages include once daily dosing, fewer side effects compared to other drug classes, high genetic barrier to resistance and a high efficacy in treatment-experienced patients.

Key Takeaways

Key players operating in the Integrase Inhibitors Market include Koninklijke TenCate (Netherlands), Low & Bonar (UK), Fibertex Nonwovens (Denmark), Thrace Group (Greece), Huesker (Germany), Berry Global (US), DuPont (US), Strata Systems (US), Leggett & Platt (US), Officine Maccaferri (Italy), GSE Environmental (US), Kaytech (South Africa), Mattex (Saudi Arabia), NAUE (Germany), Propex Operating Company (US), Carthage Mills (US), and Asahi Kasei Advance Corporation (Japan), among others.

The global integrase inhibitors market is expected to witness significant growth opportunities due to the launch of newer formulations of existing drugs and commencement of clinical trials evaluating integrase inhibitors for other therapeutic indications such as hepatitis B and coronavirus. Key pharmaceutical companies are expanding their presence globally especially in high growth emerging markets to grab a larger market share.

Market Drivers

The increasing prevalence of HIV across both developed and developing nations due to unsafe sex practices is a major factor driving the growth of the global integrase inhibitors market. According to UNAIDS, around 1.5 million new HIV infections occurred globally in 2020. Several national and international initiatives have been taken to raise awareness and provide antiretroviral treatment.

Market Restraints

However, the growth of the market is restricted by certain factors. The high costs associated with developing and production of integrase inhibitor drugs limits their widespread adoption, especially in low and middle-income countries. Patent protection expiry of major drugs is anticipated to hamper the revenue growth of large pharmaceutical companies involved in this market. Moreover, lack of awareness about HIV treatment options in underdeveloped regions acts as a restrain.

Segment Analysis

The integrase inhibitors market is dominated by the integrase strand transfer inhibitors (INSTIs) segment. The INSTIs segment accounted for over 80% market share in 2024 owing to several factors. INSTIs have demonstrated higher antiviral efficacy and genetic barrier to resistance compared to other segments. INSTIs are also better tolerated and have milder side effect profiles. Additionally, they do not require boosting with ritonavir which simplifies their use. These advantages have led to INSTIs becoming the standard of care for most HIV patients starting antiretroviral therapy.

Global Analysis

The North American region accounted for a dominant share of the global integrase inhibitors market in 2024. Higher usage of integrase inhibitors in the region's treatment guidelines, strong reimbursement structure, and presence of major pharmaceutical manufacturers are some key factors driving the North America market. The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to improving access to HIV care, increasing healthcare investments, and growing awareness regarding newer treatment options. Expanding patient support programs are also expected to support the market growth in developing countries within the Asia Pacific region. Emerging markets like China, India, Brazil, and Mexico are likely to offer high revenue opportunities for market players in the coming years.

Get more Insights on Integrase Inhibitor Market

Comments

Post a Comment

Popular posts from this blog

The Global Radioimmunoassay Market To Expand Rapidly Driven By Growing Healthcare Spending

Image
Radioimmunoassay Market The radioimmunoassay market is a critical diagnostic tool that offers accurate and sensitive detection of various substances in blood, urine, and tissues including hormones, vitamins, drugs, and tumor markers. The global radioimmunoassay market size is estimated to be valued at US$ 518.85 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period from 2024 to 2031. Radioimmunoassay is an analytical technique which measures minute quantities of biological substances like hormones, vitamins, and drugs. It has applications in various disease detection including cancer, heart disease, and diabetes. The use of radioisotopes as labels makes the assay highly sensitive and accurate for quantitative measurements. Factors such as rising chronic disease prevalence, improving access to healthcare facilities, and increasing healthcare expenditure are augmenting the demand for Radioimmunoassay Market Share globally. The Global Radioimmunoassay Market ...
Read more

Shipping Containers Market Is Driving Growth Due To Rising International Trade

Image
  - Global Shipping Container Market Shipping containers are an integral part of global trade with about 90% of non-bulk cargo transported by sea is moved in standard containers. Shipping containers allows for greater efficiency in cargo transportation by significantly reducing cargo handling and transit times. Shipping containers come in various standard sizes like 20 feet (6.1 m), 40 feet (12.2 m), 45 feet (13.7 m) and allow goods to be stacked and transported easily for domestic as well as international trade via ships, trains and trucks. The standardization of container sizes enables easy interchangeability between different modes of transportation and results in lower transportation costs. The modular design and corrosion resistance properties of containers also allow for smooth intermodal transit of goods. The global shipping containers market size is estimated to be valued at US$14484.04 billion in 2024 and is expected to exhibit a CAGR of 12% over the forecast period ...
Read more

Foldable Container House Market to Grow at Highest Pace Owing to Increasing Demand for Prefab Homes

Image
Foldable Container House Market The foldable container house market has gained immense popularity in recent times due to convenience in relocating homes and expanded living spaces. A foldable container house is built using reused shipping containers that can be easily shipped or transported to any location. These houses provide durable spaces which can withstand wear and tear, fire, floods, and other natural disasters. Foldable Container Houses are cost-effective, sustainable, and require less construction time than conventional homes. Key Takeaways Key players operating in the foldable container house market are Antares Pharma, CymaBay Therapeutics, Astellas Pharma, and AstraZeneca. These companies are developing more lightweight yet sturdy materials for containers along with innovative designs. The growing demand for prefab and easily relocatable homes has propelled the foldable container house market. The housing market faces constraints of limited land availability and high...
Read more